跳至主要内容
临床试验/NCT06570265
NCT06570265尚未招募不适用

Evaluation of Resorption, Safety, and Efficacy of Absorbable Collagen Membrane in Preventing Significant Bone Loss Following GBR (Guided Bone Regeneration) Procedure.

Hyundai Bioland Co., Ltd.0 个研究点目标入组 50 人开始时间: 2024年12月16日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
主要终点
Assessment of collagen membrane's - efficacy and safety.

研究概览

简要总结

The clinical study aims to assess the long-term safety and efficacy of the interventional medical device. The clinical study will enrol up to 50 patients aged 18 years and older, who meet specific inclusion and exclusion criteria designed to ensure patient safety and reliable data collection.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Assessment of collagen membrane's - efficacy and safety.

时间窗: 6 months after intervention

Remnants of the collagen membrane, new blood vessels formation, and the absence of inflammation in histological results.

次要结局

  • Assessment of collagen membrane's - safety.(From the beginning till the end.)
  • Change in bone dimensions(Baseline, 6 and 12 months after intervention)
  • Complication rate(7 days and 6 months after intervention)
  • VAS scale(On the day of intervention and after 1, 2, 3 days. Satisfaction - on the day of intervention.)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

RES-SAFE (Resorption, Safety, and Efficacy of... | 临床试验